FA
EW icon

Fagan Associates’s Edwards Lifesciences EW Stock Holding History

Fagan Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,092
Closed -$242K – 136
2025
Q2 		$242K Hold
3,092
– – 0.04% 117
2025
Q1 		$224K Sell
3,092
-800
-21% -$57.3K 0.04% 119
2024
Q4 		$288K Sell
3,892
-580
-13% -$40.6K 0.05% 120
2024
Q3 		$295K Hold
4,472
– – 0.05% 115
2024
Q2 		$413K Sell
4,472
-205
-4% -$18.2K 0.07% 97
2024
Q1 		$447K Hold
4,677
– – 0.08% 98
2023
Q4 		$357K Hold
4,677
– – 0.08% 92
2023
Q3 		$324K Sell
4,677
-48
-1% -$3.86K 0.08% 93
2023
Q2 		$446K Hold
4,725
– – 0.11% 84
2023
Q1 		$391K Buy
4,725
+48
+1% +$3.77K 0.1% 93
2022
Q4 		$349K Hold
4,677
– – 0.09% 99
2022
Q3 		$386K Hold
4,677
– – 0.11% 92
2022
Q2 		$445K Hold
4,677
– – 0.12% 89
2022
Q1 		$551K Hold
4,677
– – 0.11% 96
2021
Q4 		$606K Hold
4,677
– – 0.12% 93
2021
Q3 		$529K Sell
4,677
-80
-2% -$9.13K 0.12% 94
2021
Q2 		$493K Buy
4,757
+1,256
+36% +$118K 0.11% 100
2021
Q1 		$293K Sell
3,501
-34
-1% -$2.87K 0.07% 110
2020
Q4 		$322K Sell
3,535
-100
-3% -$8.29K 0.08% 101
2020
Q3 		$290K Sell
3,635
-100
-3% -$7.8K 0.08% 96
2020
Q2 		$258K Hold
3,735
– – 0.08% 96
2020
Q1 		$235K Sell
3,735
-210
-5% -$15.1K 0.09% 94
2019
Q4 		$307K Hold
3,945
– – 0.1% 103
2019
Q3 		$289K Hold
3,945
– – 0.11% 101
2019
Q2 		$243K Hold
3,945
– – 0.1% 106
2019
Q1 		$252K Hold
3,945
– – 0.11% 103
2018
Q4 		$201K Hold
3,945
– – 0.1% 105
2018
Q3 		$229K Sell
3,945
-192
-5% -$9.39K 0.09% 110
2018
Q2 		$201K Buy
+4,137
New +$193K 0.09% 111

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Fagan Associates's EW Position: Q3 2025 in Review

Fagan Associates sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 3,092 shares — an estimated $242K sold.

Fagan Associates first reported a position in EW in Q2 2018 and held it in 29 quarters. The position peaked at $606K in Q4 2021. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Fagan Associates reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Fagan Associates sold 3,092 Edwards Lifesciences shares in Q3 2025, an estimated $242K.
  • Fagan Associates first reported a position in Edwards Lifesciences in Q2 2018 and held it in 29 quarters.
  • Fagan Associates's Edwards Lifesciences position peaked at $606K in Q4 2021.
  • 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Fagan Associates's 13F filing for Q3 2025, filed 14 Nov 2025.